Business Standard

Thursday, December 26, 2024 | 12:13 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biocon dips 11% in three days on disappointing September quarter results

The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses

loss, economy, shares, stocks, market, investment, savings, gdp, growth, revenue
Premium

SI Reporter Mumbai
Shares of Biocon slipped 6.5 per cent to Rs 390 on the BSE on Monday, falling 11 per cent in the past three trading days, after the company reported lower-than-expected performance for the quarter, largely weighed by operational challenges for the quarter ended September 2020 (Q2FY21).

Biocon reported 22 per cent year on year (YoY) decline in its consolidated net profit at Rs 169 crore in Q2FY21 against Rs 216 crore in Q2FY20. Revenue from operations grew 11 per cent at Rs 1,745 crore on YoY basis.

Ebitda (earnings before interest, taxes, depreciation, and amortization) down 8 per

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in